Lisa Wilson

Affiliations: 
2017-2022 Pharmacodynamics University of Florida 
Google:
"Lisa Wilson"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wilson LL, Alleyne AR, Eans SO, et al. (2022) Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain. Molecules (Basel, Switzerland). 27
Wilson LL, Eans SO, Ramadan-Siraj I, et al. (2022) Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use. International Journal of Molecular Sciences. 23
Chakraborty S, Uprety R, Slocum ST, et al. (2021) Oxidative Metabolism as a Modulator of Kratom's Biological Actions. Journal of Medicinal Chemistry
Chakraborty S, DiBerto JF, Faouzi A, et al. (2021) A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects. Journal of Medicinal Chemistry
Romeo G, Bonanno F, Wilson LL, et al. (2021) Development of New Benzylpiperazine Derivatives as σ Receptor Ligands with Antinociceptive and Anti-Allodynic Effects. Acs Chemical Neuroscience
Wilson LL, Chakraborty S, Eans SO, et al. (2021) Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal. Cellular and Molecular Neurobiology
Wilson LL, Harris HM, Eans SO, et al. (2020) Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence. Drug and Alcohol Dependence. 216: 108310
Intagliata S, Sharma A, King TI, et al. (2020) Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo. The Aaps Journal. 22: 94
Brice-Tutt AC, Wilson LL, Eans SO, et al. (2020) Multifunctional Opioid Receptor Agonism and Antagonism by a Novel Macrocyclic Tetrapeptide Prevents Reinstatement of Morphine-Seeking Behavior. British Journal of Pharmacology
Ferracane MJ, Brice-Tutt A, Coleman J, et al. (2020) Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide [Pro-Sar-Phe-D-Phe]: a Mixed Opioid Receptor Agonist-Antagonist Following Oral Administration. Acs Chemical Neuroscience
See more...